Literature DB >> 33128579

Toll-interacting protein impacts on inflammation, autophagy, and vacuole trafficking in human disease.

Xiaoyun Li1, Gillian C Goobie1,2,3, Yingze Zhang4,5.   

Abstract

Toll-interacting protein (TOLLIP) is a ubiquitous intracellular adaptor protein involved in multiple intracellular signaling pathways. It plays a key role in mediating inflammatory intracellular responses, promoting autophagy, and enabling vacuole transport within the cell. TOLLIP is being increasingly recognized for its role in disease pathophysiology through involvement in these three primary pathways. Recent research also indicates that TOLLIP is involved in nuclear-cytoplasmic transfer, although this area requires further exploration. TOLLIP is involved in the pathophysiologic pathways associated with neurodegenerative diseases, pulmonary diseases, cardiovascular disease, inflammatory bowel disease, and malignancy. We postulate that TOLLIP plays an integral role in the disease pathophysiology of other conditions involved in vacuole trafficking and autophagy. We suggest that future research in this field should investigate the role of TOLLIP in the pathogenesis of these multiple conditions. This research has the potential to inform disease mechanisms and identify novel opportunities for therapeutic advances in multiple disease processes.

Entities:  

Keywords:  Idiopathic pulmonary fibrosis; Inflammatory bowel disease; Neoplasms; Neurodegenerative diseases; TOLLIP

Mesh:

Substances:

Year:  2020        PMID: 33128579     DOI: 10.1007/s00109-020-01999-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  63 in total

1.  Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor.

Authors:  K Burns; J Clatworthy; L Martin; F Martinon; C Plumpton; B Maschera; A Lewis; K Ray; J Tschopp; F Volpe
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

Review 2.  Tollip: a multitasking protein in innate immunity and protein trafficking.

Authors:  Daniel G S Capelluto
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

3.  Recruitment of clathrin onto endosomes by the Tom1-Tollip complex.

Authors:  Yohei Katoh; Hitoshi Imakagura; Mutsumi Futatsumori; Kazuhisa Nakayama
Journal:  Biochem Biophys Res Commun       Date:  2006-01-06       Impact factor: 3.575

4.  Negative regulation of toll-like receptor-mediated signaling by Tollip.

Authors:  Guolong Zhang; Sankar Ghosh
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

5.  Autophagic clearance of polyQ proteins mediated by ubiquitin-Atg8 adaptors of the conserved CUET protein family.

Authors:  Kefeng Lu; Ivan Psakhye; Stefan Jentsch
Journal:  Cell       Date:  2014-07-18       Impact factor: 41.582

6.  Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-β signaling pathway.

Authors:  Lu Zhu; Lingdi Wang; Xiaolin Luo; Yongxian Zhang; Qiurong Ding; Xiaomeng Jiang; Xiao Wang; Yi Pan; Yan Chen
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

7.  Toll-Interacting Protein, Tollip, Inhibits IL-13-Mediated Pulmonary Eosinophilic Inflammation in Mice.

Authors:  Yoko Ito; Niccolette Schaefer; Amelia Sanchez; David Francisco; Rafeul Alam; Richard J Martin; Julie G Ledford; Connor Stevenson; Di Jiang; Liwu Li; Monica Kraft; Hong Wei Chu
Journal:  J Innate Immun       Date:  2018-01-27       Impact factor: 7.349

8.  Signal Transduction and Intracellular Trafficking by the Interleukin 36 Receptor.

Authors:  Siddhartha S Saha; Divyendu Singh; Ernest L Raymond; Rajkumar Ganesan; Gary Caviness; Christine Grimaldi; Joseph R Woska; Detlev Mennerich; Su-Ellen Brown; M Lamine Mbow; C Cheng Kao
Journal:  J Biol Chem       Date:  2015-08-12       Impact factor: 5.157

9.  Tollip and Tom1 form a complex and recruit ubiquitin-conjugated proteins onto early endosomes.

Authors:  Yohei Katoh; Yoko Shiba; Hiroko Mitsuhashi; Yuko Yanagida; Hiroyuki Takatsu; Kazuhisa Nakayama
Journal:  J Biol Chem       Date:  2004-03-26       Impact factor: 5.157

Review 10.  Toll-Interacting Protein in Resolving and Non-Resolving Inflammation.

Authors:  Elizabeth J A Kowalski; Liwu Li
Journal:  Front Immunol       Date:  2017-05-05       Impact factor: 7.561

View more
  5 in total

1.  Inflammatory bowel disease and risk of idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis.

Authors:  Jiali Wang; Fushun Kou; Xiao Han; Lei Shi; Rui Shi; Zhibin Wang; Tangyou Mao; Junxiang Li
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

Review 2.  Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle.

Authors:  Xiaoyun Li; Gillian C Goobie; Alyssa D Gregory; Daniel J Kass; Yingze Zhang
Journal:  Am J Respir Cell Mol Biol       Date:  2021-05       Impact factor: 6.914

3.  Somatostatin attenuates intestinal epithelial barrier injury during acute intestinal ischemia-reperfusion through Tollip/Myeloiddifferentiationfactor 88/Nuclear factor kappa-B signaling.

Authors:  Yan Tian; Ruo Shu; Yi Lei; Yu Xu; Xinfeng Zhang; Huayou Luo
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  Tollip-deficient zebrafish display no abnormalities in development, organ morphology or gene expression in response to lipopolysaccharide.

Authors:  Lidia Wolińska-Nizioł; Karolina Romaniuk; Karolina Wojciechowska; Krzysztof Surga; Maciej Kamaszewski; Hubert Szudrowicz; Marta Miączyńska
Journal:  FEBS Open Bio       Date:  2022-06-27       Impact factor: 2.792

5.  Role of miRNA-324-5p-Modified Adipose-Derived Stem Cells in Post-Myocardial Infarction Repair.

Authors:  Zhou Ji; Chan Wang; Qing Tong
Journal:  Int J Stem Cells       Date:  2021-08-30       Impact factor: 2.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.